Kimberly Burns
Nurse Practitioner · Arma, KSNPI 1205143609
Payments from drug & device makers
Across 68 payments — averaging $18.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$275
- AbbVie$213
- Lilly USA, LLC$156
- Dexcom, Inc.$136
- Globus Medical$74
- Amgen$64
- plus $365 from 14 others
What the payments were for
- Food & beverage$1,283100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 3 | $275 |
| AbbVie | 14 | $213 |
| Lilly USA, LLC | 6 | $156 |
| Dexcom, Inc. | 19 | $136 |
| Globus Medical | 2 | $74 |
| Amgen | 4 | $64 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Boehringer Ingelheim | 2 | $39 |
| Abbott | 2 | $38 |
| Tandem Diabetes Care, Inc. | 2 | $29 |
| BETA Bionics, Inc. | 1 | $29 |
| Novartis | 1 | $28 |
| Chiesi USA, Inc. | 1 | $27 |
| BD | 1 | $22 |
| Eisai Inc. | 1 | $21 |
| Pfizer | 1 | $18 |
| Novo Nordisk | 1 | $17 |
| Radius Health, Inc. | 1 | $17 |
| Medtronic | 1 | $17 |
| Genentech USA, Inc. | 3 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,283 in reported general payments places this provider in the 80th percentile of 1,326 nurse practitioner providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 36 | $33,294 |
| MounjaroTirzepatide | 23 | $24,511 |
| RybelsusSemaglutide | 15 | $22,382 |
| EliquisApixaban | 34 | $21,307 |
| TrulicityDulaglutide | 16 | $16,225 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 46 | $15,850 |
| Aimovig AutoinjectorErenumab-Aooe | 11 | $8,143 |
| Advair HfaFluticasone Propion/Salmeterol | 21 | $6,321 |
| Sucralfate | 33 | $4,094 |
| TradjentaLinagliptin | 13 | $2,754 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $2,613 |
| Potassium Chloride | 70 | $2,538 |
| Novolog FlexpenInsulin Aspart | 17 | $2,442 |
| Ezetimibe | 20 | $2,064 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 22 | $1,870 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $17 | $55,67751 claims |
| Lilly USA, LLCMounjaro, Trulicity | $156 | $40,73639 claims |
| PfizerEliquis | $18 | $21,30734 claims |
| Boehringer IngelheimTradjenta | $39 | $2,75413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,326 nurse practitioner providers in Kansas.
Other nurse practitioner in Arma
- Gary GrafTopeka$726K
- Sarah FitzmauriceKansas City$247K
- Anna ShortRoeland Park$215K
- Shannon GreggTopeka$140K
- Morteza RabiiOverland Park$88K
- Constance JacobWichita$65K
- Michelle KirkHutchinson$58K
- Catherine PowellWichita$50K
- Lori RanalloWestwood$48K
- Kristyn MilburnPleasanton$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.